Ravivo 750 mg Tab

Nchi: Yordani

Lugha: Kiingereza

Chanzo: JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

Viambatanisho vya kazi:

Levofloxacin 750 mg

Inapatikana kutoka:

مستودع أدوية الجناح الشرقي - eastward drugstore

ATC kanuni:

J01MA12

INN (Jina la Kimataifa):

Levofloxacin 750 mg

Kipimo:

750 mg

Vitengo katika mfuko:

7 Tab

Viwandani na:

DROGSAN ILACLARI SANAYI VE TICARET A.S/TURKEY (تركيا)

Bidhaa muhtasari:

6.55 :سعر الجمهور + الضريبة

Taarifa za kipeperushi

PATIENT INFORMATION LEAFLET
WARNING: WARNING: TENDINITIS AND TENDON RUPTURE
(inflammation and rupture of the muscles that bind the muscles
to the bones), PERIPHERAL NEUROPATHY (disturbances in
the distant nerves for any reason - loss of sensation),
CENTRAL NERVOUS SYSTEM EFFECTS (central nervous
system) and MYASTHENIA GRAVIS SERIOUS UNWANTED
EFFECTS, INCLUDING EXACERBATION
Fluoroquinolones, including RAVIVO, can cause disabling
and irreversible undesirable effects such as:
o Tendonitis and tendon (the ligaments that attach the
muscles to the bones) rupture
o Peripheral neuropathy (disorders of distal nerves for
any reason - loss of sensation)
o Central nervous system effects
Ravivo should be discontinued immediately and fluoro-
quinolones should be avoided in patients who experience
any of these reactions.
Fluoroquinolones, including RAVIVO, may exacerbate muscle
weakness in patients with myasthenia gravis. The use of
RAVIVO should be avoided in patients with a known history
of myasthenia gravis.
Since fluoroquinolone group drugs, including RAVIVO, are
known to be associated with serious side effects, they can be
used in the following indications if there is no other alternative.
o Acute bacterial sinusitis (acute inflammation of the air
void inside the facial bones caused by bacteria)
o Uncomplicated urinary tract infection
o Acute bacterial exacerbation of chronic bronchitis
(re-exacerbation of persistent inflammation of the bronchial
tubes-membranes of the lung)
RAVIVO
750 mg Film Coated Tablet
It is taken orally.
_• ACTIVE SUBSTANCE:_ 768,69 mg levofloxacin hemihydrate
equivalent to 750 mg levofloxacin
_• EXCIPIENTS:_ Microcrystalline cellulose (Avicel PH102),
crospovidone, hydroxypropyl methyl cellulose, sodium
stearyl fumarate, polyvinyl alcohol, titanium dioxide,
polyethylene glycol, talc.
Please read these LEAFLET carefully before you start
using this medicine because it contains important
information for you.
-
Keep these leaflet. You can need to read again.
-
If you have other questions, please talk